-+ 0.00%
-+ 0.00%
-+ 0.00%

*Esperion: Renata Agreed Not to Market Generic Version of Either NEXLETOL or NEXLIZET in U.S. Prior to April 19, 2040, Unless Certain Limited Circumstances Occur

Dow Jones·10/07/2026 12:08:08